Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
Price:
25.54 USD
0.04%
Market Closed
Updated:
Jun 1, 2024
Deciphera Pharmaceuticals Inc
Change in Working Capital
|
Deciphera Pharmaceuticals Inc
Change in Working Capital Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Change in Working Capital Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Deciphera Pharmaceuticals Inc
NASDAQ:DCPH
|
Change in Working Capital
-$8.7m
|
CAGR 3-Years
23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Change in Working Capital
$3.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
38%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Change in Working Capital
-$2.2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-5%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Change in Working Capital
-$422m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-7%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Change in Working Capital
-$275.3m
|
CAGR 3-Years
-158%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Change in Working Capital
$105.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Deciphera Pharmaceuticals Inc's Change in Working Capital?
Change in Working Capital
-8.7m
USD
-8.7m
USD
Based on the financial report for Mar 31, 2024, Deciphera Pharmaceuticals Inc's Change in Working Capital amounts to -8.7m USD.
What is Deciphera Pharmaceuticals Inc's Change in Working Capital growth rate?
Change in Working Capital CAGR 3Y
23%
23%
Over the last year, the Change in Working Capital growth was 64%. The average annual Change in Working Capital growth rates for Deciphera Pharmaceuticals Inc have been 23% over the past three years .
You don't have any saved screeners yet
